A nitroglycerin patch is a medicated adhesive applied to the skin that delivers a steady dose of nitroglycerin over many hours, primarily to prevent angina (chest pain caused by reduced blood flow to the heart). Unlike sublingual nitroglycerin tablets that dissolve under the tongue for quick relief during an attack, the patch is worn continuously to keep the drug circulating at low, sustained levels. What makes the patch unusual among heart medications is the strict requirement for a daily “off” period, typically around 10 to 12 hours without the patch, to keep it working at all.
What the Patch Actually Does in the Body
Nitroglycerin is a vasodilator, meaning it relaxes and widens blood vessels. Once the drug passes through the skin and enters the bloodstream, it is converted into nitric oxide, a molecule that signals smooth muscle in vessel walls to relax. This relaxation has two useful effects for someone with coronary artery disease. First, it opens up the coronary arteries themselves, allowing more blood to reach the heart muscle. Second, it dilates veins throughout the body, which reduces the volume of blood returning to the heart and thereby lowers the heart’s workload. The net result is that the heart needs less oxygen, and the supply-demand mismatch that triggers angina is eased.
The patch delivers the drug transdermally, meaning it passes through the skin into the bloodstream without requiring the digestive tract. After application, nitroglycerin levels in the blood rise over the first couple of hours and then remain relatively stable as long as the patch stays on. The drug is metabolized quickly once it enters the bloodstream, breaking down into less active compounds called glyceryl dinitrate metabolites.
How Well It Works for Angina
Controlled trials from the late 1980s established that transdermal nitroglycerin patches reduce both the frequency of angina attacks and the need for rescue nitroglycerin tablets. In one trial of patients with stable angina, wearing a patch cut angina episodes by about 31% and reduced consumption of sublingual nitroglycerin tablets by roughly 34% compared with a placebo patch. Exercise capacity also improved: patients could exercise about 29% longer three hours after applying the patch and still showed a 16% improvement at 24 hours.1PubMed. Efficacy of a new transdermal nitroglycerin patch (Deponit 10) for stable angina pectoris Another trial in 27 patients confirmed that angina attacks and tablet use dropped significantly during both short-term and long-term patch therapy compared with placebo.2The American Journal of Cardiology. Acute and chronic efficacy of 10 mg of nitroglycerin patch in stable angina pectoris
Beyond angina prevention, there is evidence that higher-dose patches can help the heart recover after a heart attack. A multicenter trial found that a 0.4 mg/hour patch significantly reduced both the end-systolic and end-diastolic volume of the left ventricle, markers of harmful remodeling that can lead to heart failure. The benefit was most pronounced in patients whose heart’s pumping ability was already impaired, with ejection fractions at or below 40%.3Circulation. Transdermal nitroglycerin patch therapy improves left ventricular function and prevents remodeling after acute myocardial infarction This use is less common in daily practice than angina prevention, but it illustrates the drug’s broader cardiovascular effects.
Why You Have to Take It Off Every Day
One of the most counterintuitive things about the nitroglycerin patch is that wearing it around the clock makes it stop working. The body develops tolerance to continuous nitroglycerin exposure surprisingly fast, sometimes within 24 to 48 hours. The vessels essentially adapt to the constant presence of nitric oxide and stop responding. The standard fix is intermittent therapy: you wear the patch for about 12 to 14 hours and then remove it for a 10-to-12-hour nitrate-free interval, usually overnight. This schedule has been shown to preserve the drug’s effectiveness in treating stable angina and preventing tolerance.4PubMed. Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval
The trade-off is that the patch-free window leaves you without protection during that period. For many patients this window is overnight, when physical exertion is low and angina episodes are less likely. But for some people, particularly those who experience early-morning angina, the gap in coverage is a real clinical concern. Doctors sometimes add a different class of anti-anginal drug, like a beta-blocker or calcium channel blocker, to provide background protection during the hours the patch is off.
The Rebound Problem
The tolerance issue has a twin: rebound. When nitroglycerin wears off after a sustained period of use, some patients experience a temporary worsening of angina symptoms that goes beyond simply returning to their baseline. Blood vessels can become more reactive or constricted than they were before the drug was started. Research suggests this rebound phenomenon may stem from a form of endothelial dysfunction that develops after nitroglycerin is discontinued, with coronary arteries becoming overly responsive to constricting signals.5PubMed. Nitroglycerin withdrawal increases endothelium-dependent vasomotor response to acetylcholine
Reviews of the rebound literature have noted considerable variation in how often and how severely it occurs, and have emphasized that the risk can be reduced by using other anti-anginal medications during the nitrate-free period or by avoiding abrupt drops in blood nitroglycerin levels.6PubMed. Risk of rebound phenomenon during nitrate withdrawal In practical terms, if your doctor prescribes a nitroglycerin patch, you should not stop using it suddenly without guidance, and you should not skip your other heart medications during the off-hours just because you feel fine.
Common Side Effects
Headache is the most frequent side effect, and for many people it is the reason they want to stop using the patch. The headache occurs because the same vasodilation that helps the heart also widens blood vessels in the head. Research into nitrate-induced headaches has identified at least two distinct patterns: an immediate headache tied directly to the vasodilation caused by nitric oxide release, and a delayed migraine-like headache that appears to involve different pathways, including the release of a neuropeptide called calcitonin gene-related peptide and changes in ion channel function.7PubMed Central. Headache-type adverse effects of NO donors: vasodilation and beyond The encouraging news is that the immediate headache tends to diminish over the first several days of use as the body partially adjusts. Taking a mild analgesic during the first week can help most people get through this adjustment period without abandoning therapy.
Other common side effects include dizziness, lightheadedness (especially when standing up quickly), and a drop in blood pressure. These are dose-related and usually manageable by starting at a lower dose and increasing gradually. Skin irritation at the application site is also common. A prospective study of 33 patients wearing nitroglycerin patches for more than a week found that about 15% developed skin reactions, though patch testing confirmed these were mainly irritant reactions rather than true allergic contact dermatitis, and they did not require stopping the medication.8Wiley Online Library (Contact Dermatitis). Skin acceptance of transcutaneous nitroglycerin patches: a prospective study of 33 patients Rotating the application site daily and avoiding hairy or irritated skin are standard recommendations.
The Nitrate-PDE5 Inhibitor Interaction
If there is one drug interaction every nitroglycerin patch user needs to know about, it is the combination with phosphodiesterase-5 (PDE5) inhibitors, the class that includes sildenafil, tadalafil, and vardenafil, commonly prescribed for erectile dysfunction. Both nitroglycerin and PDE5 inhibitors lower blood pressure through overlapping pathways, and combining them can produce a severe, sometimes life-threatening drop in blood pressure. A study published in Circulation documented large and sudden decreases in systemic blood pressure in patients who took sildenafil alongside nitroglycerin. In patients with narrowed coronary arteries, the combination also reduced coronary blood flow, compounding the danger.9PubMed. Effects of sildenafil citrate (Viagra) combined with nitrate on the heart
All three commonly used PDE5 inhibitors are formally contraindicated in patients taking any form of organic nitrate, including patches.10PubMed. Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions Simply removing the patch does not make it safe to take one of these drugs immediately, because nitroglycerin levels take time to clear. The general guidance is to wait at least 24 hours after removing a patch before taking a PDE5 inhibitor, though your doctor may adjust that based on the specific drug and dose.
Off-Label Uses Beyond the Heart
Because nitroglycerin is fundamentally a vasodilator, researchers have tested topical or transdermal formulations for a variety of conditions that involve poor blood flow or tissue healing. Several of these uses have accumulated meaningful evidence, even though they remain off-label.
Chronic Tendon Pain
One of the more surprising applications is the use of nitroglycerin patches for chronic Achilles tendinopathy, the stubborn tendon pain familiar to many runners and recreational athletes. Nitric oxide appears to play a role in tendon repair, and supplying it locally may accelerate healing. A randomized controlled trial found that patients who applied a small nitroglycerin patch over their Achilles tendon reported less pain with activity, less night pain, and less local tenderness by 12 weeks compared with a placebo patch. The improvement persisted at six months, with an estimated 14% more tendons classified as completely asymptomatic in the nitroglycerin group.11PubMed. Topical glyceryl trinitrate for chronic Achilles tendinopathy The patches used for tendon therapy are typically cut to deliver a much smaller dose than those used for angina, which limits systemic side effects like headache.
Raynaud’s Phenomenon
People with Raynaud’s phenomenon experience exaggerated blood vessel spasms in their fingers and toes in response to cold or stress, turning the digits white and causing pain. This is especially common and severe in people with systemic sclerosis (scleroderma). A laser Doppler imaging study found that applying a nitroglycerin patch to the hand in patients with systemic sclerosis increased blood flow and hand temperature, and produced faster recovery of circulation after a cold challenge.12PubMed. Laser Doppler imaging evaluation of nitroglycerin patch application in systemic sclerosis patients A separate study confirmed that a low-dose patch improved blood flow, raised local temperature, and improved quality of life and daily function in patients with secondary Raynaud’s.13Revista Colombiana de ReumatologÃa (English Edition). Effectiveness of glyceryl trinitrate patch use in secondary Raynaud’s phenomenon While oral vasodilators like calcium channel blockers remain first-line treatment, nitroglycerin patches offer a topical alternative for people who cannot tolerate systemic medications or need additional relief.
IV Site Preservation and Uterine Relaxation
Placing a small nitroglycerin patch near an intravenous catheter site has been studied as a way to prevent phlebitis (vein inflammation) and extravasation (leakage of fluid into tissue), complications that plague patients requiring long-term intravenous therapy. A review concluded that transdermal nitroglycerin is a reasonable option for patients who need IV infusions lasting longer than about 50 hours.14Annals of Pharmacotherapy. Transdermal Nitroglycerin for the Prevention of Intravenous Infusion Failure Due to Phlebitis and Extravasation
Nitroglycerin’s smooth-muscle-relaxing properties have also been explored in obstetrics, where uterine relaxation can be helpful for managing preterm labor or facilitating certain procedures. A systematic review found that nitroglycerin was more effective than placebo for arresting preterm labor, though it did not outperform standard tocolytic drugs like ritodrine or magnesium sulfate. For uterine relaxation during cesarean delivery or external version (turning a breech baby), nitroglycerin was not superior to placebo.15PubMed Central. Nitroglycerin as a uterine relaxant: a systematic review
Safety Hazards That Are Easy to Overlook
Several safety concerns with nitroglycerin patches are not widely known, even among regular users.
Some older patch designs contain metallic foil backing. If you are wearing a patch when you receive external cardiac defibrillation (either from an automated external defibrillator or in a hospital setting), the electrical current can arc through the metal and cause a skin burn. The same applies to magnetic resonance imaging (MRI). Case reports have documented burns from both situations involving nitroglycerin patches and other transdermal medications like nicotine patches.16EP Europace. Analgesic patches and defibrillators: a cautionary tale The practical takeaway is to always tell emergency personnel and MRI technicians about any patches you are wearing. Many newer patch formulations have moved away from metallic components, but it is worth checking with your pharmacist if you are scheduled for an MRI.
Used patches still contain residual nitroglycerin. This creates a disposal hazard, particularly in households with children or pets. Reports to medication safety organizations have flagged cases of unintentional exposure to discarded transdermal patches, including nitroglycerin patches, leading to medication errors.17Journal of Emergency Nursing. A Sticky Situation: Toxicity of Clonidine and Fentanyl Transdermal Patches in Pediatrics Folding a used patch in half with the sticky sides together and placing it in household trash out of reach of children is the standard advice, though some guidelines recommend flushing certain transdermal medications. Ask your pharmacist which approach applies to your specific patch.
Occupational Nitroglycerin Exposure
The relationship between nitroglycerin and the heart has a grim occupational history that predates therapeutic patches by decades. Workers in explosives and munitions factories who handled nitroglycerin daily developed chronic vasodilation during the workweek, along with headaches (nicknamed “bang head”). When they went home for the weekend and exposure stopped abruptly, the sudden withdrawal triggered coronary artery spasm. A case report described a 34-year-old munitions worker who suffered an unexplained cardiac arrest on a Sunday morning; in retrospect, the event fit the syndrome of withdrawal from chronic occupational nitroglycerin exposure, and prior weekend chest pain episodes matched the same pattern.18PubMed. Cardiac arrest in an explosives factory worker due to withdrawal from nitroglycerin exposure
This occupational phenomenon is essentially the same rebound effect that concerns cardiologists today when prescribing intermittent patch therapy, just in an uncontrolled and far more dangerous form. The munitions industry’s experience with “Monday disease” (symptoms returning each Monday as workers’ bodies readapted to nitroglycerin) was actually one of the early clues that chronic nitrate exposure changes vascular tone in ways that persist after the drug is gone.
A Brief History of Nitroglycerin in Medicine
Nitroglycerin was first synthesized in 1847 by the Italian chemist Ascanio Sobbrero, who was primarily interested in its explosive properties. Alfred Nobel later made it the core ingredient of dynamite. The compound’s medical career began in the 1860s and 1870s: the Scottish physician Lauder Brunton first used a related compound, amyl nitrite, for angina in 1867, and in 1879 the English physician William Murrell described the therapeutic benefits of nitroglycerin itself for angina pectoris.19PubMed. Explosive discovery, surprising future: The extraordinary journey of nitroglycerin, nitroderivatives and nitric oxide For more than a century after Murrell’s work, nitroglycerin was given as sublingual tablets or as ointment smeared on the chest. The transdermal patch system arrived in the 1980s, offering the convenience of once-daily application and more predictable drug levels. Ironically, the tolerance problem that prompted the intermittent dosing schedule was discovered only after the patches were already widely marketed, leading to a period of controversy about whether they worked at all when worn continuously. The intermittent regimen resolved most of that controversy, and the patches remain a standard option for chronic angina management today.